Weekly News Recap #Phispers
India to have BMS’ largest R&D facility after US; its drug plants to face increased FDA inspections
This week’s Phispers has a lot of news from India. First, Bristol Myers Squibb (BMS) inaugurated a US$ 100 million facili...
Impressions : 1952
Aurobindo’s sartan banned in Europe; Dr. Reddy’s cost optimization drive continues, sells off another site
This week, Phispers brings you news from Dr. Reddy’s Laboratories in India which is divesting its API plant in Hyderabad ...
Impressions : 3867
Aceto wins case for use of foreign API in US government contracts; GSK may split
This week in Phispers, we bring you news about a landmark court ruling
in the US that permitted Aceto to supply drugs to the U...
Impressions : 1819
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.